1. Home
  2. CGTX vs CURR Comparison

CGTX vs CURR Comparison

Compare CGTX & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • CURR
  • Stock Information
  • Founded
  • CGTX 2007
  • CURR 2013
  • Country
  • CGTX United States
  • CURR Singapore
  • Employees
  • CGTX N/A
  • CURR N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • CURR Business Services
  • Sector
  • CGTX Health Care
  • CURR Consumer Discretionary
  • Exchange
  • CGTX Nasdaq
  • CURR Nasdaq
  • Market Cap
  • CGTX 158.8M
  • CURR 151.4M
  • IPO Year
  • CGTX 2021
  • CURR N/A
  • Fundamental
  • Price
  • CGTX $1.74
  • CURR $1.85
  • Analyst Decision
  • CGTX Strong Buy
  • CURR Strong Buy
  • Analyst Count
  • CGTX 3
  • CURR 1
  • Target Price
  • CGTX $2.83
  • CURR $3.50
  • AVG Volume (30 Days)
  • CGTX 2.1M
  • CURR 215.1K
  • Earning Date
  • CGTX 11-12-2025
  • CURR 11-18-2025
  • Dividend Yield
  • CGTX N/A
  • CURR N/A
  • EPS Growth
  • CGTX N/A
  • CURR N/A
  • EPS
  • CGTX N/A
  • CURR N/A
  • Revenue
  • CGTX N/A
  • CURR $41,092,419.00
  • Revenue This Year
  • CGTX N/A
  • CURR N/A
  • Revenue Next Year
  • CGTX N/A
  • CURR $14.56
  • P/E Ratio
  • CGTX N/A
  • CURR N/A
  • Revenue Growth
  • CGTX N/A
  • CURR N/A
  • 52 Week Low
  • CGTX $0.22
  • CURR $0.33
  • 52 Week High
  • CGTX $3.83
  • CURR $7.08
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 51.92
  • CURR 62.34
  • Support Level
  • CGTX $1.67
  • CURR $1.67
  • Resistance Level
  • CGTX $2.00
  • CURR $1.97
  • Average True Range (ATR)
  • CGTX 0.16
  • CURR 0.09
  • MACD
  • CGTX 0.02
  • CURR 0.02
  • Stochastic Oscillator
  • CGTX 59.48
  • CURR 76.74

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.

Share on Social Networks: